From the passage of the One Big Beautiful Bill to CMS’s newly announced strategic direction, from executive orders on pharmaceutical pricing to ongoing scrutiny of PBMs, Medicaid and the 340B program, there’s no shortage of movement across the healthcare landscape. At first glance, these efforts may seem disconnected. Actually, they reflect a growing recognition of [...]

View Entire Post